Growth Hormone Peptide Research
Sermorelin is a growth hormone releasing hormone (GHRH) analogue consisting of the first 29 amino acids of naturally occurring GHRH. This synthetic peptide demonstrates selective binding affinity to GHRH receptors in the anterior pituitary, making it a valuable tool for researchers investigating growth hormone regulation pathways. Laboratory studies examine sermorelin’s mechanism of action in stimulating endogenous growth hormone secretion through modulation of hypothalamic-pituitary axis functions. Research institutions utilise this compound to study pulsatile hormone release patterns and explore the relationship between GHRH analogues and somatotroph cell responses in controlled experimental conditions. The peptide’s bioactive properties allow scientists to investigate growth factor cascades and examine cellular signalling mechanisms involved in growth hormone regulation. Our Stroid UK Shop maintains strict quality standards for all peptide compounds.
Laboratory Research Applications
In vitro studies with sermorelin focus on receptor binding characteristics and downstream signalling pathway activation. Researchers evaluate the peptide’s selectivity profile compared to native GHRH and examine its effects on cyclic adenosine monophosphate (cAMP) production in cellular models. Animal model studies investigate the compound’s pharmacokinetic properties and dose-response relationships in growth hormone secretion. Laboratory protocols examine sermorelin’s stability under various storage conditions and analyse its interaction with growth hormone releasing peptide receptors. Academic institutions studying endocrine physiology incorporate this compound into research examining age-related changes in growth hormone secretion and investigating potential therapeutic applications for growth hormone deficiency conditions. Scientists also study the peptide’s role in sermorelin acetate research programmes examining metabolic regulation pathways.
Technical Specifications
| Parameter | Specification |
|---|---|
| Molecular Weight | 3357.88 g/mol |
| CAS Number | 86168-78-7 |
| Sequence Length | 29 amino acids |
| Purity | ≥98% (HPLC) |
| Form | Lyophilised powder |
| Storage | -20°C, dry conditions |
| Reconstitution | Sterile water or appropriate buffer |
This compound exhibits stability in lyophilised form when stored at appropriate temperatures. Research protocols recommend reconstitution with sterile diluents and immediate use or short-term storage at 2-8°C. Laboratories should verify peptide integrity through analytical methods before experimental use. Quality control measures include mass spectrometry confirmation and amino acid analysis to ensure sequence accuracy. Our technical documentation provides detailed handling procedures for optimal research outcomes in selective compound research and peptide investigation studies.
Research Compliance Information
This sermorelin preparation is supplied exclusively for in-vitro laboratory research and analytical testing applications. The compound is not intended for human consumption, clinical use, or any therapeutic applications. Researchers must maintain appropriate safety protocols when handling peptide compounds and ensure compliance with institutional research guidelines. Storage and handling procedures should follow standard laboratory practices for bioactive peptides. This product is manufactured under controlled conditions to meet research-grade specifications and is intended solely for qualified research institutions and licensed laboratories conducting legitimate scientific investigations.
